Plus Therapeutics reported $-5.74M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Baxter International USD 66M 280.2M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
Northwest Biotherapeutics USD -14.32M 481K Sep/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Starpharma Holdings AUD -873K 1.43M Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 758M 271M Mar/2026